Quarterly EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortisation) was ₹62.6 crore, up 15.1% year-over-year.

The approval is for 500 mg, 750 mg, and 1,000 mg strengths. The medicine is used to manage cholesterol levels in patients ...

Revenue from operations also recorded a healthy increase of 35.8% to ₹108.2 crore in Q4 FY25 from ₹79.7 crore in Q4 FY24.

Revenue from operations also went up during the quarter. It climbed 11% year-on-year to ₹1,170 crore from ₹1,054 crore in Q4 ...

This is the first such announcement by the company in over a period of nine years that the company will be issuing bonus ...

The ophthalmic solution is used to decrease intraocular pressure in open-angle glaucoma or ocular hypertension patients.

Ather Energy’s IPO is an important event of the company where it intends to raise money for its business expansion. The offer ...

Tejas Networks has created a complete suite of D2M network infra solutions, both hardware and software, to enable ...

The firm signed an agreement to deliver O&M services for 675 MWp of solar power projects of a leading Indian renewable energy ...

Praj informed the bourses that it has also established a Centre of Excellence (CoE) and Innovation for Biopolymers in ...

The revenue from operations of the company registered a healthy 23.8% YoY growth, to ₹282.7 crore in the quarter ending March ...

On a quarter-on-quarter basis, the company’s net profit slipped 30.90% against ₹4,649 Crore in the previous quarter.